A Clinical Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of SRT501 in Subjects With Colorectal Cancer and Hepatic Metastases

NCT00920803 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms, Colorectal

Interventions

DRUG: Placebo
DRUG: SRT501

Sponsor

Sirtris, a GSK Company

Collaborators

[object Object]